The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Efstratios Charitos

Showing 1-2 of 2 articles
Interventions for valvular disease
One-Year Clinical Outcomes of a Novel Transcatheter Heart Valve to treat Degenerated Surgical Valves - The “VIVALL” study
Schaefer U, Butter C, Landt M, Frerker C, Treede H, Schirmer J, Koban C, Allali A, Schmidt T, Charitos E, Nikolayevska O, Conradi L
March 30, 2021 | 10.4244/EIJ-D-20-01241
Interventions for valvular disease
Thirty-day outcomes of a novel transcatheter heart valve to treat degenerated surgical valves: the VIVALL multicentre, single-arm, pilot study
Schäfer U, Butter C, Landt M, Frerker C, Treede H, Schirmer J, Koban C, Allali A, Schmidt T, Charitos E, Conradi L
October 4, 2019 | 10.4244/EIJ-D-19-00331

Latest news

NEW ISSUE
Robotics, AI and Imaging State of The Art; Bleeding Risk and Mortality in CAD; Treating Refractory Angina by Coronary Sinus Narrowing; and more
September 20, 2021
STATE OF THE ART
Robotics, imaging, and artificial intelligence in the catheterisation laboratory
Rafael Beyar et al.
September 20, 2021
AHEAD OF PRINT
ViV TAVI vs repeat SAVR
Monil Majmundar et al.
September 15, 2021
AHEAD OF PRINT
Thrombectomy for ischaemic stroke
Christopher A. Rajkumar et al.
September 10, 2021
EDITORIAL
Walking the tightrope between ischaemia and bleeding
Michelle L. O’Donoghue et al.
September 20, 2021
EDITORIAL
Microvascular dysfunction endotypes and outcomes
Christos V. Bourantas et al.
September 20, 2021
EDITORIAL
Coronary sinus reducer therapy for refractory angina: is it ready for prime time?
Michael Foley et al.
September 20, 2021
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke